Phase II Evaluation of IV Melphalan (L-PAM) and Whole Body Hyperthermia (WBH) for Malignant Melanoma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Melphalan (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 02 Oct 2015 Biomarkers information updated
- 24 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Feb 2008 Status changed from completed to in progress, in accordance with clinicaltrials.gov.